Navigation Links
Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
Date:5/7/2008

WASHINGTON, May 7 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, presented today at a major scientific meeting findings from analyses of pivotal trial results of INTUNIV, a selective alpha-2A-agonist. This compound is an investigational once-daily medication, which is being evaluated for the treatment of the symptoms of Attention Deficit Hyperactivity Disorder (ADHD). The data demonstrated that INTUNIV showed significant efficacy in reducing ADHD symptoms for patients taking the medication when compared to patients taking placebo at all measured time points up to 24 hours postdose.

The U.S. Food and Drug Administration (FDA) issued an approvable letter on June 20, 2007, regarding INTUNIV. Shire is conducting additional clinical work which is designed to enhance the label. Upon approval, INTUNIV will be the first selective alpha-2A receptor agonist indicated for the treatment of ADHD that may provide an important treatment option for patients and physicians.

Summary of Analyses

The pooled analysis evaluated results from these patients on a weight adjusted mg/kg basis from two similarly designed, randomized, double-blind, forced-dose titration, multicenter phase III trials. The primary efficacy measure for both studies was change in the ADHD Rating Scale (ADHD-RS-IV) total score from baseline to endpoint. All patient groups treated with INTUNIV showed significantly greater improvement in ADHD-RS-IV total score from baseline to endpoint than the placebo group (P<.001). The ADHD-RS-IV is a standardized, validated test for assessing symptoms of ADHD and for assessing their response to treatment.

The analysis also studied duration of effect using the Conners' Parent Rating Scale-Revised Short Form (CPRS-R), which is a comprehensive scale that used observer and self-report ratings to help assess ADHD and evaluate behavioral issues in children and adolescents. The CPRS-R asses
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
2. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
3. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
4. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
5. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
6. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
7. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
8. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
9. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
10. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
11. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015   HeartWare International, Inc ... invasive, miniaturized circulatory support technologies that are revolutionizing the treatment ... Doug Godshall , is scheduled to present at the ... Las Vegas on Thursday, May 14, ... The live webcast of the Company,s presentation at the conference ...
(Date:5/4/2015)... CARLSBAD, Calif. , May 4, 2015  Isis ... an exclusive license agreement with Bayer HealthCare (Bayer) to ... of thrombosis. Under the terms of the agreement, Isis ... near-term payments, including an immediate $100 million up-front payment ... program following a Phase 2 study in patients with ...
(Date:5/4/2015)... , May 4, 2015 MEI Pharma, ... focused on the clinical development of novel therapies ... mitochondria-specific effects of the Company,s investigational drug candidate ... activity when combined with a tyrosine-kinase inhibitor (TKI). ... to be a potent inhibitor of mitochondrial oxidative ...
Breaking Medicine Technology:HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5
... NATICK, Mass., Nov. 25, 2011  RegenoCELL Therapeutics, Inc. (OTCBB: ... is pleased to announce that its wholly owned subsidiary ... with several potential new distributors.  It is anticipated that ... and begin purchasing cell processing services in the near ...
... Biopharmaceutical Company Moleac has announced the launch in France and ... supplement engineered to stimulate neuroplasticity and recovery. NurAiD II is ... operated by Moleac and a growing number of pharmacies across ... to support the restoration of neurological functions: ...
Cached Medicine Technology:Regenocell in Negotiations With Potential New Distributors to Increase Patient Flow 2Regenocell in Negotiations With Potential New Distributors to Increase Patient Flow 3Moleac Announces the Launch of NurAiD II in France, a "Recovery Stimulator" Marketed as a Natural Food Supplement 2Moleac Announces the Launch of NurAiD II in France, a "Recovery Stimulator" Marketed as a Natural Food Supplement 3
(Date:5/4/2015)... (PRWEB) May 04, 2015 Elisabeth ... created a stir and showed the healthcare fraternity ... major healthcare procedure, the downside of balance billing. ... a healthcare provider billing a patient for the ... to reimburse and what the provider chooses to ...
(Date:5/4/2015)... 2015 In response to the ... Task Force (USPSTF), Strategic Radiology® (SR®) fully aligns ... Obstetricians and Gynecologists (ACOG), the American College Of ... Cancer Society (ACS), American College of Radiology (ACR), ... recommend regular screening mammography for women beginning at ...
(Date:5/4/2015)... World T.E.A.M. Sports’ best-attended Face ... the last decade arrived in this historic Civil War ... days from the Pentagon in Arlington, Virginia. The annual ... and able-bodied participants work together to successfully complete the ... the commitment and sacrifices by military veterans in their ...
(Date:5/4/2015)... 04, 2015 Scanmarket, a leading provider ... been included in the just-released Spend Matters “50 to ... Spend Matters " 50 To Know " listing is ... Scanmarket’s commitment to providing comprehensive, easy-to-use strategic sourcing solutions ... “There are many well-established and respected companies on this ...
(Date:5/4/2015)... 04, 2015 Fast on the heels ... Trace Amounts, and Allison Folmar, JD, join over 150 ... internationally. , On Sunday, May 24, the conference presents ... possible?" Are you interested in Ryan Hinds' recovery story? ... our war against autism was written by Marcia ...
Breaking Medicine News(10 mins):Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4Health News:Scanmarket Selected to Spend Matters "50 To Know" List of Companies in Procurement Sector. 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4
... very famous Texan, the late Byron Nelson, is considered one ... his unprecedented, still-unbroken record of 11 consecutive tournament wins (18 ... of his short 15-year professional career ending in 1945, his ... excellence not only in sport, but in every aspect of ...
... of virus, genome should make finding a vaccine easier, CDC ... the genes that make up the new H1N1 swine flu ... a decade, researchers reported Friday. , Scientists at the U.S. ... genomes of more than 50 samples of the swine flu ...
... Honored by National Coalition for Homeless VeteransWASHINGTON, May 22 ... Unsung Hero Award at the 2009 Conference of the ... Iraq with the 10th Mountain Division. In 2006, ... sustained devastating injuries from an IED explosion that cost ...
... 22 Oklahoma Governor Brad Henry yesterday signed into ... reform legislation ever passed by the Oklahoma legislative and ... passage of the comprehensive reform by a vote of ... Oklahoma House of Representatives earlier that day by an ...
... Event raises $480,000 to make vital health and human ... More than 5,000 people converged on Angel Stadium ... annual rally against HIV/AIDS. Donations from OC AIDS ... and children are living with HIV/AIDS in our community. ...
... Texas, May 22 Animal welfare advocates throughout Texas ... position to oppose House Bill 3180, a bill to ... mills. "The TVMA,s decision to put the commercial ... animals suffering in puppy mills is appalling," said Cile ...
Cached Medicine News:Health News:The Byron Nelson: Championship Philosophy, Timeless Excellence 2Health News:The Byron Nelson: Championship Philosophy, Timeless Excellence 3Health News:Swine Flu Genes Went Undetected for Years: Report 2Health News:Swine Flu Genes Went Undetected for Years: Report 3Health News:Swine Flu Genes Went Undetected for Years: Report 4Health News:Swine Flu Genes Went Undetected for Years: Report 5Health News:Swine Flu Genes Went Undetected for Years: Report 6Health News:Swine Flu Genes Went Undetected for Years: Report 7Health News:Swine Flu Genes Went Undetected for Years: Report 8Health News:Swine Flu Genes Went Undetected for Years: Report 9Health News:Swine Flu Genes Went Undetected for Years: Report 10Health News:Swine Flu Genes Went Undetected for Years: Report 11Health News:Swine Flu Genes Went Undetected for Years: Report 12Health News:Oklahoma Passes Comprehensive Tort Reform: Governor Brad Henry Signs Reform Legislation 2Health News:Thousands Rally in Anaheim to Help People With HIV/AIDS 2Health News:Veterinary Group Opposes Bill to Clean Up Puppy Mill Industry 2
24-Well Slot Blot...
... vacuum plate, reservoir seal O-ring, sealing frame, assorted ... vacuum blotter quickly and efficiently transfers DNA or ... membrane. Because it generally requires only 90 min ... separated on a gel, transferred to a membrane, ...
... Includes vacuum pump, vacuum regulator, base ... seal O-ring, sealing frame, assorted window gaskets, ... blotter quickly and efficiently transfers DNA or ... nylon membrane. Because it generally requires only ...
Inquire...
Medicine Products: